A Novel Liposomal S-Propargyl-Cysteine: A Sustained Release of Hydrogen Sulfide Reducing Myocardial Fibrosis via TGF-β1/Smad Pathway

References

• Bazhanov N, Ansar M, Ivanciuc T, Garofalo RP, Casola A. Hydrogen sulfide: a novel player in airway development, pathophysiology of respiratory diseases, and antiviral defenses. Am J Respir Cell Mol Biol. 2017;57(4):403–410. doi:10.1165/rcmb.2017-0114TR28481637
   PubMed Web of Science ®Google Scholar
• Chan SJ, Wong PT. Hydrogen sulfide in stroke: protective or deleterious? Neurochem Int. 2017;105:1–10. doi:10.1016/j.neuint.2016.11.01528174023
   PubMed Web of Science ®Google Scholar
• Wang R. Physiological implications of hydrogen sulfide: a whiff exploration that blossomed. Physiol Rev. 2012;92(2):791–896. doi:10.1152/physrev.00017.201122535897
   PubMed Web of Science ®Google Scholar
• Shibuya N, Koike S, Tanaka M, et al. A novel pathway for the production of hydrogen sulfide from D-cysteine in mammalian cells. Nat Commun. 2013;4:1366. doi:10.1038/ncomms237123340406
   PubMed Web of Science ®Google Scholar
• Kanagy NL, Szabo C, Papapetropoulos A. Vascular biology of hydrogen sulfide. Am J Physiol Cell Physiol. 2017;312(5):C537–C549. doi:10.1152/ajpcell.00329.201628148499
   PubMed Web of Science ®Google Scholar
• Sivarajah A, Collino M, Yasin M, et al. Anti-apoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial I/R. Shock. 2009;31(3):267–274. doi:10.1097/SHK.0b013e318180ff8918636044
   PubMedGoogle Scholar
• Hosoki R, Matsuki N, Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun. 1997;237(3):527–531. doi:10.1006/bbrc.1997.68789299397
   PubMed Web of Science ®Google Scholar
• Cai WJ, Wang MJ, Moore PK, et al. The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. Cardiovasc Res. 2007;76(1):29–40. doi:10.1016/j.cardiores.2007.05.02617631873
   PubMed Web of Science ®Google Scholar
• Szabo C, Papapetropoulos A. Hydrogen sulphide and angiogenesis: mechanisms and applications. Br J Pharmacol. 2011;164(3):853–865. doi:10.1111/bph.2011.164.issue-321198548
   PubMed Web of Science ®Google Scholar
• Tao BB, Liu SY, Zhang CC, et al. VEGFR2 functions as an H2S-targeting receptor protein kinase with its novel Cys1045-Cys1024 disulfide bond serving as a specific molecular switch for hydrogen sulfide actions in vascular endothelial cells. Antioxid Redox Signal. 2013;19(5):448–464. doi:10.1089/ars.2012.456523199280
   PubMed Web of Science ®Google Scholar
• Geng B, Chang L, Pan C, et al. Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochem Biophys Res Commun. 2004;318(3):756–763. doi:10.1016/j.bbrc.2004.04.09415144903
   PubMed Web of Science ®Google Scholar
• Zhu YZ, Wang ZJ, Ho P, et al. Hydrogen sulfide and its possible roles in myocardial ischemia in experimental rats. J Appl Physiol (1985). 2007;102(1):261–268. doi:10.1152/japplphysiol.00096.200617038495
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhao X, Jin H, et al. Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol. 2009;29(2):173–179. doi:10.1161/ATVBAHA.108.17933318988885
   PubMed Web of Science ®Google Scholar
• Xin H, Wang M, Tang W, et al. Hydrogen sulfide attenuates inflammatory hepcidin by reducing IL-6 secretion and promoting SIRT1-mediated STAT3 deacetylation. Antioxid Redox Signal. 2016;24(2):70–83. doi:10.1089/ars.2015.631526154696
   PubMedGoogle Scholar
• Zhou YF, Wu XM, Zhou G, et al. Cystathionine beta-synthase is required for body iron homeostasis. Hepatology. 2018;67(1):21–35. doi:10.1002/hep.2949928859237
   PubMedGoogle Scholar
• Zhong G, Chen F, Cheng Y, Tang C, Du J. The role of hydrogen sulfide generation in the pathogenesis of hypertension in rats induced by inhibition of nitric oxide synthase. J Hypertens. 2003;21(10):1879–1885. doi:10.1097/00004872-200310000-0001514508194
   PubMed Web of Science ®Google Scholar
• Qingyou Z, Junbao D, Weijin Z, et al. Impact of hydrogen sulfide on carbon monoxide/heme oxygenase pathway in the pathogenesis of hypoxic pulmonary hypertension. Biochem Biophys Res Commun. 2004;317(1):30–37. doi:10.1016/j.bbrc.2004.02.17615047144
   PubMed Web of Science ®Google Scholar
• Pan LL, Liu XH, Gong QH, Yang HB, Zhu YZ. Role of cystathionine gamma-lyase/hydrogen sulfide pathway in cardiovascular disease: a novel therapeutic strategy? Antioxid Redox Signal. 2012;17(1):106–118. doi:10.1089/ars.2011.434922017202
   PubMed Web of Science ®Google Scholar
• Kashfi K, Olson KR. Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras. Biochem Pharmacol. 2013;85(5):689–703. doi:10.1016/j.bcp.2012.10.01923103569
   PubMed Web of Science ®Google Scholar
• Zhao Y, Biggs TD, Xian M. Hydrogen sulfide (H2S) releasing agents: chemistry and biological applications. Chem Commun (Camb). 2014;50(80):11788–11805. doi:10.1039/C4CC00968A25019301
   PubMed Web of Science ®Google Scholar
• Rose P, Whiteman M, Moore PK, Zhu YZ. Bioactive S-alk(en)yl cysteine sulfoxide metabolites in the genus Allium: the chemistry of potential therapeutic agents. Nat Prod Rep. 2005;22(3):351–368. doi:10.1039/b417639c16010345
   PubMed Web of Science ®Google Scholar
• Liang YH, Shen YQ, Guo W, Zhu YZ. SPRC protects hypoxia and re-oxygenation injury by improving rat cardiac contractile function and intracellular calcium handling. Nitric Oxide. 2014;41:113–119. doi:10.1016/j.niox.2014.05.01024887754
   PubMed Web of Science ®Google Scholar
• Wang Q, Wang XL, Liu HR, Rose P, Zhu YZ. Protective effects of cysteine analogues on acute myocardial ischemia: novel modulators of endogenous H(2)S production. Antioxid Redox Signal. 2010;12(10):1155–1165. doi:10.1089/ars.2009.294719842912
   PubMedGoogle Scholar
• Huang C, Kan J, Liu X, et al. Cardioprotective effects of a novel hydrogen sulfide agent-controlled release formulation of S-propargyl-cysteine on heart failure rats and molecular mechanisms. PLoS One. 2013;8(7):e69205. doi:10.1371/journal.pone.006920523874913
   PubMedGoogle Scholar
• Kan J, Guo W, Huang C, et al. S-propargyl-cysteine, a novel water-soluble modulator of endogenous hydrogen sulfide, promotes angiogenesis through activation of signal transducer and activator of transcription 3. Antioxid Redox Signal. 2014;20(15):2303–2316. doi:10.1089/ars.2013.544924180631
   PubMed Web of Science ®Google Scholar
• Zheng YT, Zhu JH, Ma G, et al. Preclinical assessment of the distribution, metabolism, and excretion of S-propargyl-cysteine, a novel H2S donor, in Sprague-Dawley rats. Acta Pharmacol Sin. 2012;33(6):839–844. doi:10.1038/aps.2012.1522543704
   PubMedGoogle Scholar
• Tran BH, Huang C, Zhang Q, et al. Cardioprotective effects and pharmacokinetic properties of a controlled release formulation of a novel hydrogen sulfide donor in rats with acute myocardial infarction. Biosci Rep. 2015;35:3. doi:10.1042/BSR20140185
   Web of Science ®Google Scholar
• Eloy JO, Claro DSM, Petrilli R, et al. Liposomes as carriers of hydrophilic small molecule drugs: strategies to enhance encapsulation and delivery. Colloids Surf B Biointerfaces. 2014;123:345–363. doi:10.1016/j.colsurfb.2014.09.02925280609
   PubMed Web of Science ®Google Scholar
• Davis ME, Chen ZG, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov. 2008;7(9):771–782. doi:10.1038/nrd261418758474
   PubMed Web of Science ®Google Scholar
• Han HD, Byeon Y, Jeon HN, Shin BC. Enhanced localization of anticancer drug in tumor tissue using polyethylenimine-conjugated cationic liposomes. Nanoscale Res Lett. 2014;9(1):209. doi:10.1186/1556-276X-9-20924855464
   PubMedGoogle Scholar
• Kneidl B, Peller M, Winter G, Lindner LH, Hossann M. Thermosensitive liposomal drug delivery systems: state of the art review. Int J Nanomedicine. 2014;9:4387–4398. doi:10.2147/IJN.S4929725258529
   PubMed Web of Science ®Google Scholar
• Liu M, Li M, Wang G, et al. Heart-targeted nanoscale drug delivery systems. J Biomed Nanotechnol. 2014;10(9):2038–2062. doi:10.1166/jbn.2014.189425992448
   PubMed Web of Science ®Google Scholar
• Verma DD, Levchenko TS, Bernstein EA, Mongayt D, Torchilin VP. ATP-loaded immunoliposomes specific for cardiac myosin provide improved protection of the mechanical functions of myocardium from global ischemia in an isolated rat heart model. J Drug Target. 2006;14(5):273–280. doi:10.1080/1061186060076310316882547
   PubMed Web of Science ®Google Scholar
• Takahama H, Minamino T, Asanuma H, et al. Prolonged targeting of ischemic/reperfused myocardium by liposomal adenosine augments cardioprotection in rats. J Am Coll Cardiol. 2009;53(8):709–717. doi:10.1016/j.jacc.2008.11.01419232905
   PubMed Web of Science ®Google Scholar
• Care NRCU, Animals AUOL. Guide for the Care and Use of Laboratory Animals. 2011.
   Google Scholar
• Zheng Y, Liu H, Ma G, et al. Determination of S-propargyl-cysteine in rat plasma by mixed-mode reversed-phase and cation-exchange HPLC-MS/MS method and its application to pharmacokinetic studies. J Pharm Biomed Anal. 2011;54(5):1187–1191. doi:10.1016/j.jpba.2010.11.02721156344
   PubMedGoogle Scholar
• Tan B, Jin S, Sun J, et al. New method for quantification of gasotransmitter hydrogen sulfide in biological matrices by LC-MS/MS. Sci Rep. 2017;7:46278. doi:10.1038/srep4627828406238
   PubMedGoogle Scholar
• Calvert JW, Elston M, Nicholson CK, et al. Genetic and pharmacologic hydrogen sulfide therapy attenuates ischemia-induced heart failure in mice. Circulation. 2010;122(1):11–19. doi:10.1161/CIRCULATIONAHA.109.92099120566952
   PubMed Web of Science ®Google Scholar
• Kolluru GK, Shen X, Bir SC, Kevil CG. Hydrogen sulfide chemical biology: pathophysiological roles and detection. Nitric Oxide. 2013;35:5–20. doi:10.1016/j.niox.2013.07.00223850632
   PubMed Web of Science ®Google Scholar
• Liu YH, Lu M, Hu LF, et al. Hydrogen sulfide in the mammalian cardiovascular system. Antioxid Redox Signal. 2012;17(1):141–185. doi:10.1089/ars.2011.400522304473
   PubMed Web of Science ®Google Scholar
• Mustafa AK, Sikka G, Gazi SK, et al. Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels. Circ Res. 2011;109(11):1259–1268. doi:10.1161/CIRCRESAHA.111.24024221980127
   PubMed Web of Science ®Google Scholar
• Szabo C, Ransy C, Modis K, et al. Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part I. Biochemical and physiological mechanisms. Br J Pharmacol. 2014;171(8):2099–2122. doi:10.1111/bph.1236923991830
   PubMed Web of Science ®Google Scholar
• Tang G, Yang G, Jiang B, et al. H(2)S is an endothelium-derived hyperpolarizing factor. Antioxid Redox Signal. 2013;19(14):1634–1646. doi:10.1089/ars.2012.480523418650
   PubMed Web of Science ®Google Scholar
• Yin WL, He JQ, Hu B, Jiang ZS, Tang XQ. Hydrogen sulfide inhibits MPP(+)-induced apoptosis in PC12 cells. Life Sci. 2009;85(7–8):269–275. doi:10.1016/j.lfs.2009.05.02319540852
   PubMedGoogle Scholar
• Mani S, Untereiner A, Wu L, Wang R. Hydrogen sulfide and the pathogenesis of atherosclerosis. Antioxid Redox Signal. 2014;20(5):805–817. doi:10.1089/ars.2013.532423582095
   PubMed Web of Science ®Google Scholar
• Zhao H, Lu S, Chai J, et al. Hydrogen sulfide improves diabetic wound healing in ob/ob mice via attenuating inflammation. J Diabetes Complications. 2017;31(9):1363–1369. doi:10.1016/j.jdiacomp.2017.06.01128720320
   PubMed Web of Science ®Google Scholar
• Shimizu Y, Polavarapu R, Eskla KL, et al. Hydrogen sulfide regulates cardiac mitochondrial biogenesis via the activation of AMPK. J Mol Cell Cardiol. 2018;116:29–40.29408195
   PubMed Web of Science ®Google Scholar
• Guan Q, Wang X, Gao L, et al. Hydrogen sulfide suppresses high glucose-induced expression of intercellular adhesion molecule-1 in endothelial cells. J Cardiovasc Pharmacol. 2013;62(3):278–284. doi:10.1097/FJC.0b013e31829875ef23676335
   PubMed Web of Science ®Google Scholar
• Wu WJ, Jia WW, Liu XH, et al. S-propargyl-cysteine attenuates inflammatory response in rheumatoid arthritis by modulating the Nrf2-ARE signaling pathway. Redox Biol. 2016;10:157–167. doi:10.1016/j.redox.2016.08.01127744121
   PubMed Web of Science ®Google Scholar
• Wagner A, Vorauer-Uhl K. Liposome technology for industrial purposes. J Drug Deliv. 2011;2011:591325. doi:10.1155/2011/59132521490754
   PubMedGoogle Scholar
• Stern ST, Martinez MN, Stevens DM. When is it important to measure unbound drug in evaluating nanomedicine pharmacokinetics? Drug Metab Dispos. 2016;44(12):1934–1939. doi:10.1124/dmd.116.07314827670412
   PubMedGoogle Scholar
• Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev. 2013;65(1):36–48. doi:10.1016/j.addr.2012.09.03723036225
   PubMed Web of Science ®Google Scholar
• Gabizon A, Shmeeda H, Horowitz AT, Zalipsky S. Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates. Adv Drug Deliv Rev. 2004;56(8):1177–1192. doi:10.1016/j.addr.2004.01.01115094214
   PubMed Web of Science ®Google Scholar
• Knop K, Hoogenboom R, Fischer D, Schubert US. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew Chem Int Ed Engl. 2010;49(36):6288–6308. doi:10.1002/anie.20090267220648499
   PubMed Web of Science ®Google Scholar
• Mann AP, Bhavane RC, Somasunderam A, et al. Thioaptamer conjugated liposomes for tumor vasculature targeting. Oncotarget. 2011;2(4):298–304. doi:10.18632/oncotarget.v2i421666286
   PubMedGoogle Scholar
• Mao Y, Wang J, Zhao Y, et al. A novel liposomal formulation of FTY720 (fingolimod) for promising enhanced targeted delivery. Nanomedicine-Uk. 2014;10(2):393–400. doi:10.1016/j.nano.2013.08.001
   PubMed Web of Science ®Google Scholar
• Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. J Heart Lung Transplant. 2002;21(2):189–203. doi:10.1016/S1053-2498(01)00776-811834347
   PubMedGoogle Scholar
• Wencker D, Chandra M, Nguyen K, et al. A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest. 2003;111(10):1497–1504. doi:10.1172/JCI1766412750399
   PubMed Web of Science ®Google Scholar
• Cowie MR. BNP-guided therapy for chronic heart failure: anything more than just an attractive concept? Eur Heart J. 2014;35(23):1507–1509. doi:10.1093/eurheartj/ehu13424713648
   PubMedGoogle Scholar
• Tsutamoto T, Tanaka T, Sakai H, et al. Beneficial effect of perindopril on cardiac sympathetic nerve activity and brain natriuretic peptide in patients with chronic heart failure: comparison with enalapril. Circ J. 2008;72(5):740–746. doi:10.1253/circj.72.74018441453
   PubMedGoogle Scholar
• Qian X, Li X, Ma F, et al. Novel hydrogen sulfide-releasing compound, S-propargyl-cysteine, prevents STZ-induced diabetic nephropathy. Biochem Biophys Res Commun. 2016;473(4):931–938. doi:10.1016/j.bbrc.2016.03.15427055593
   PubMed Web of Science ®Google Scholar
• Chen MM, Lam A, Abraham JA, Schreiner GF, Joly AH. CTGF expression is induced by TGF- beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. J Mol Cell Cardiol. 2000;32(10):1805–1819. doi:10.1006/jmcc.2000.121511013125
   PubMed Web of Science ®Google Scholar
• Deten A, Holzl A, Leicht M, Barth W, Zimmer HG. Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats. J Mol Cell Cardiol. 2001;33(6):1191–1207. doi:10.1006/jmcc.2001.138311444923
   PubMed Web of Science ®Google Scholar
• Leask A. Potential therapeutic targets for cardiac fibrosis: tGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ Res. 2010;106(11):1675–1680. doi:10.1161/CIRCRESAHA.110.21773720538689
   PubMed Web of Science ®Google Scholar
• Sun L, Jin H, Sun L, et al. Hydrogen sulfide alleviates myocardial collagen remodeling in association with inhibition of TGF-beta/Smad signaling pathway in spontaneously hypertensive rats. Mol Med. 2015;20:503–515. doi:10.2119/molmed.2013.0009625222913
   PubMed Web of Science ®Google Scholar